BioSpace News Archive

Saisystems Health has partnered with Rectangle Health to provide its clients with software that helps to maximize patient payment collection via a contactless process, keeping patients and staff safe and secure.

Peter C. Adamson, MD, Global Head, Oncology Drug Development & Lead, Pediatric Innovations Group, Sanofi, Inc., and past chair of National Cancer Institute supported Children’s Oncology Group, will be keynoting the Canines-N-Kids Foundation’s 2nd Paws for a Cure Research Symposium.

Presentation to include recent and upcoming developments and overview of drug candidate JAN101 for the potential treatment of peripheral artery disease (PAD) as well as potential applications for COVID-19 vascular complications and planned IND submission process with FDA [19-August-2020] LAS VEGAS , Aug. 19, 2020 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a company fo

GI Windows Medical Corp, a clinical-stage, privately-held medical device company, announced a $16.4 million Series A-1 financing.

PruittHealth today announced plans to significantly expand its infection preventionist network in order to dedicate resources to more of its skilled nursing centers.

GoHealth, Inc. (GoHealth) (Nasdaq: GOCO), a leading health insurance marketplace, announced financial results for the three and six months ended June 30, 2020.

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2020 Wells Fargo Virtual Healthcare Conference via webcast on Wednesday, September 9, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:00 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through October

- CONTROL Trial Investigates Anti-diarrheal Strategies Including Dose Escalation in Neratinib-treated Patients with Early Stage HER2-positive Breast Cancer - Dose Escalation Resulted in Reduced Rate, Severity and Duration of Grade ≥ 3 Diarrhea Compared to Phase III ExteNET Trial, Lower Diarrhea-related Discontinuations and Dose Reductions in Multiple CONTROL Cohorts LOS ANGELES--( BUSINESS WIRE )-- Puma Biotechnology, Inc. (NASDAQ: PBYI), a b

With mounting scientific evidence confirming health risks associated with electromagnetic field (EMF) exposure, expert physicians and scientists from across the globe will convene for the Electromagnetic Fields Medical Conference on January 28-31, 2021

India Globalization Capital, Inc. (NYSE American: IGC) today announced financial results for the quarter ended June 30, 2020, which is the first quarter of its 2021 fiscal year.